Policy research: Using evidence to improve healthcare delivery systems

Circulation

Volumn 119, Issue 6, 2009, Pages 891-898

  Ross, Joseph S ^a,b   Gross, Cary P ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delivery of health care; Health policy; Policy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ARTICLE; BEHAVIOR; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; POLITICS; POPULATION RESEARCH; PRIORITY JOURNAL; SOCIAL SECURITY;

HEALTH POLICY; HUMANS; POLICY MAKING; RESEARCH DESIGN;

EID: 61949305319     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.729855     Document Type: Article

References (92)

1. Frieden TR, Mostashari F, Kerker BD, Miller N, Hajat A, Frankel M. Adult tobacco use levels after intensive tobacco control measures: New York City, 2002-2003. Am J Public Health. 2005;95:1016-1023.
2. Okie S. New York to trans fats: you're out! N Engl J Med. 2007;356: 2017-2021.
3. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, Krumholz HM, Vogel RA. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
4. Marciniak TA, Ellerbeck EF, Radford MJ, Kresowik TF, Gold JA, Krumholz HM, Riefe CI, Allman RM, Vogel RA, Jencks SF. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351-1357.
5. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623-629.
6. O'Connor GT, Quinten HB, Traven ND, Ramunno LD, Dodds TA, Marciniak TA, Wennberg JE. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA. 1999;281:627-633.
7. Berk ML, Schur CL, Feldman J. Twenty-five years of health surveys: does more data mean better data? Health Aff (Millwood). 2007;26:1599-1611.
8. Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA. 2000;284:2061-2069.
9. Ross JS, Bradley EH, Busch SH. Use of health care services by lower-income and higher-income uninsured adults. JAMA. 2006;295: 2027-2036.
10. Banthin JS, Bernard DM. Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003. JAMA. 2006;296:2712-2719.
11. Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract. 2007;8:234-242.
12. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
13. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG. Differences in medical care and disease outcomes among black and white women with heart disease. Circulation. 2003;108:1089-1094.
14. Rathore SS, Berger AK, Weinfurt KP, Feinleib M, Oetgen WJ, Gersh BJ, Schulman KA. Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation. 2000;102:642-648.
15. Sloan FA, Trogdon JG, Curtis LH, Schulman KA. Does the ownership of the admitting hospital make a difference? Outcomes and process of care of Medicare beneficiaries admitted with acute myocardial infarction. Med Care. 2003;41:1193-1205.
16. Asch SM, Sloss EM, Hogan C, Brook RH, Kravitz RL. Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims. JAMA. 2000;284:2325-2333.
17. Adams EK, Thorpe KE, Becker ER, Joski PJ, Flome J. Colorectal cancer screening, 1997-1999: role of income, insurance and policy. Prev Med. 2004;38:551-557.
18. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002;162: 2581-2586.
19. Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296: 2815-2822.
20. Wennberg JE, Fisher ES, Skinner JS. Geography and the debate over Medicare reform. Health Aff (Millwood). 2002;suppl Web exclusives: W96-W114.
21. Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, Kahn K, Merrick N, Solomon DH. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med. 1986;314:285-290.
22. Chassin MR, Kosecoff J, Park RE, Winslow CM, Kahn KL, Merrick NJ, Keesey J, Fink A, Solomon DH, Brook RH. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA. 1987;258:2533-2537.
23. Holahan J, Berenson RA, Kachavos PG. Area variations in selected Medicare procedures. Health Aff (Millwood). 1990;9:166-175.
24. Wennberg JE, Freeman JL, Shelton RM, Bubolz TA. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med. 1989;321:1168-1173.
25. Fisher ES. Medical care: is more always better? N Engl J Med. 2003; 349:1665-1667.
26. Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev. 2006;15:12-18.
27. Newhouse JP, Manning WG, Morris CN, Orr LL, Duan N, Keeler EB, Leibowitz A, Marquis KH, Marquis MS, Phelps CE, Brook RH. Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med. 1981;305:1501-1507.
28. Brook RH, Ware JE Jr, Rogers WH, Keeler EB, Davies AR, Donald CA, Goldberg GA, Lohr KN, Masthay PC, Newhouse JP. Does free care improve adults' health? Results from a randomized controlled trial. N Engl J Med. 1983;309:1426-1434.
29. Lohr KN, Brook RH, Kamberg CJ, Goldberg GA, Leibowitz A, Keesey J, Reboussin D, Newhouse JP. Use of medical care in the Rand Health Insurance Experiment: diagnosis- and service-specific analyses in a randomized controlled trial. Med Care. 1986;24:S1-S87.
30. Siu AL, Sonnenberg FA, Manning WG, Goldberg GA, Bloomfield ES, Newhouse JP, Brook RH. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med. 1986;315:1259-1266.
31. Krumholz HM, Wang Y, Mattera JA, Wang Y, Han LF, Ingber MJ, Roman S, Normand SL. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation. 2006;113: 1683-1692.
32. Krumholz HM, Wang Y, Mattera JA, Wang Y, Han LF, Ingber MJ, Roman S, Normand SL. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation. 2006;113:1693-1701.
33. Chassin MR, Hannan EL, DeBuono BA. Benefits and hazards of reporting medical outcomes publicly. N Engl J Med. 1996;334:394-398.
34. Hannan EL, Kilburn H Jr, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994;271:761-766.
35. Hannan EL, Kumar D, Racz M, Siu AL, Chassin MR. New York State's Cardiac Surgery Reporting System: four years later. Ann Thorac Surg. 1994;58:1852-1857.
36. Hannan EL, Sarrazin MS, Doran DR, Rosenthal GE. Provider profiling and quality improvement efforts in coronary artery bypass graft surgery: the effect on short-term mortality among Medicare beneficiaries. Med Care. 2003;41:1164-1172.
37. Hannan EL, Siu AL, Kumar D, Kilburn H Jr, Chassin MR. The decline in coronary artery bypass graft surgery mortality in New York State: the role of surgeon volume. JAMA. 1995;273:209-213.
38. Peterson ED, DeLong ER, Jollis JG, Muhlbaier LH, Mark DB. The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly. J Am Coll Cordial. 1998;32:993-999.
39. Omoigui NA, Miller DP, Brown KJ, Annan K, Cosgrove D III, Lytle B, Loop F, Topol EJ. Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation. 1996;93:27-33.
40. Ghali WA, Ash AS, Hall RE, Moskowitz MA. Statewide quality improvement initiatives and mortality after cardiac surgery. JAMA. 1997; 277:379-382.
41. Rosenthal GE, Quinn L, Harper DL. Declines in hospital mortality associated with a regional initiative to measure hospital performance. Am J Med Qual. 1997;12:103-112.
42. Baker DW, Einstadter D, Thomas CL, Husak SS, Gordon NH, Cebul RD. Mortality trends during a program that publicly reported hospital performance. Med Care. 2002;40:879-890.
43. Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA. 2001; 286:1732-1739.
44. Conover CJ, Sloan FA. Does removing certificate-of-need regulations lead to a surge in health care spending? J Health Polit Policy Law. 1998;23:455-481.
45. Sloan FA, Steinwald B. Effects of regulation on hospital costs and input use. J Law Econ. 1980;23:81-109.
46. Ho V, Ross JS, Nallamothu BK, Krumholz HM. Cardiac certificate of need regulations and the availability and use of revascularization services. Am Heart J. 2007;154:767-775.
47. DiSesa VJ, O'Brien SM, Welke KF, Beland SM, Haan CK, Vaughan-Sarrazin MS, Peterson ED. Contemporary impact of state certificate-of-need regulations for cardiac surgery: an analysis using the Society of Thoracic Surgeons' National Cardiac Surgery Database. Circulation. 2006;114:2122-2129.
48. Ho V. Certificate of need, volume, and percutaneous transluminal coronary angioplasty outcomes. Am Heart J. 2004;147:442-448.
49. Popescu I, Vaughan-Sarrazin MS, Rosenthal GE. Certificate of need regulations and use of coronary revascularization after acute myocardial infarction. JAMA. 2006;295:2141-2147.
50. Vaughan-Sarrazin MS, Hannan EL, Gormley CJ, Rosenthal GE. Mortality in Medicare beneficiaries following coronary artery bypass graft surgery in states with and without certificate of need regulation. JAMA. 2002;288:1859-1866.
51. Robinson JL, Nash DB, Moxey E, O'Connor JP. Certificate of need and the quality of cardiac surgery. Am J Med Qual. 2001;16:155-160.
52. Ross JS, Ho V, Wang Y, Cha SS, Epstein AJ, Masoudi FA, Nallamothu BK, Krumholz HM. Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction. Circulation. 2007;115:1012-1019.
53. Reeves B, ed. Health Services Research Methods: A Guide to Best Practice. 1st ed. Oxford, UK: Blackwell Publishing Limited; 1998.
54. Spasoff RA. Epidemiological Methods for Health Policy. Oxford, UK: Oxford University Press; 1999.
55. Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ; GUSTO-1 Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565-572.
56. Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM; GUSTO-1 Investigators. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA. 1996;275:777-782.
57. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343:8-15.
58. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
59. Gross CP, Garg PP, Krumholz HM. The generalizability of observational data to elderly patients was dependent on the research question in a systematic review. J Clin Epidemiol. 2005;58:130-137.
60. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006;296:1377-1384.
61. Gross CP, Filardo G, Mayne ST, Krumholz HM. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005;103:483-491.
62. Krumholz HM, Gross CP, Peterson ED, Barron HV, Radford MJ, Parsons LS, Every NR. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J. 2003;146:839-847.
63. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146:250-257.
64. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-2726.
65. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328-3334.
66. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892.
67. Bradley EH, Curry LA, Webster TR, Mattera JA, Roumanis SA, Radford MJ, McNamara RL, Barton BA, Berg DN, Krumholz HM. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation. 2006;113:1079-1085.
68. Bradley EH, Roumanis SA, Radford MJ, Webster TR, McNamara RL, Mattera JA, Barton BA, Berg DN, Portnay EL, Moscovitz H, Parkosewich J, Holmboe ES, Blaney M, Krumholz HM. Achieving door-to-balloon times that meet quality guidelines: how do successful hospitals do it? J Am Coll Cardiol. 2005;46:1236-1241.
69. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, Roumanis SA, Curtis JP, Nallamothu BK, Magid DJ, McNamara RL, Parkosewich J, Loeb JM, Krumholz HM. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006;355:2308-2320.
70. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357:2109-2122.
71. Bradley EH, Herrin J, Elbel B, McNamara RL, Magid DJ, Nallamothu BK, Wang Y, Normand SL, Spertus JA, Krumholz HM. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA. 2006;296:72-78.
72. Wodchis WP, Ross JS, Detsky AS. Is P4P really FFS? JAMA. 2007;298: 1797-1799.
73. Ibrahim JG, Chen M-H, Lipsitz SR, Herring AH. Missing-data methods for generalized linear models: a comparative review. J Am Stat Assoc. 2005;100:332-346.
74. Normand SL, Zou KH. Sample size considerations in observational health care quality studies. Stat Med. 2002;21:331-345.
75. Harris KM, Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv Res. 1998;33:1337-1360.
76. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
77. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293:2908-2917.
78. Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction. JAMA. 2005;293:1329-1337.
79. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007; 297:278-285.
80. Hiatt RA. HIPAA: the end of epidemiology, or a new social contract? Epidemiology. 2003;14:637-639.
81. Nosowsky R, Giordano TJ. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy rule: implications for clinical research. Annu Rev Med. 2006;57:575-590.
82. Krieger N. Data, "race," and politics: a commentary on the epidemiological significance of California's Proposition 54. J Epidemiol Community Health. 2004;58:632-633.
83. Coalition for Health Services Research. Federal Funding for Health Services Research. December 2006. Available at: http://www.chsr.org/ AHfundingreport1206.pdf. Accessed February 19, 2008.
84. Levit K, Smith C, Cowan C, Sensenig A, Catlin A. Health spending rebound continues in 2002. Health Aff (Millwood). 2004;23:147-159.
85. US Department of Health and Human Services. FY 2006 Budget in Brief, Centers for Medicare & Medicaid Services. Available at: http://www.hhs.gov/ budget/06budget/centersformed.html. Accessed February 19, 2008.
86. U.S. Department of Veteran Affairs. Fiscal year 2008 budget estimates. Available at: http://www.va.gov/budget/summary/VolumeIMedicalPrograms.pdf. Accessed February 19, 2008.
87. Kassirer JP. On The Take: How America's Complicity With Big Business Can Endanger Your Health. New York, NY: Oxford University Press; 2004.
88. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289: 454-465.
89. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999;282:1453-1457.
90. Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx? BMJ. 2007;334:120-123.
91. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338:101-106.
92. AcademyHealth. Ethical guidelines for managing conflicts of interest in health services research. December 2004. Available at: http://www.academyhealth. org/ethics/report.pdf. Accessed February 19, 2008.